COVID-19 vaccines for patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status | Poverty Infectious Diseases
COVID-19 vaccines for patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status |  Poverty Infectious Diseases

COVID-19 vaccines for patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status | Poverty Infectious Diseases

  • Shahidsales S, Aledavood SA, Joudi M, Molaie F, Esmaily H, Javadinia SA. COVID-19 in cancer patients may be presented by atypical symptoms and higher mortality, a case-controlled study from Iran. Cancer Rep (Hoboken). 2021; 4 (5): e1378.

    CAS

    Google Scholar

  • Taghizadeh-Hesary F, Porouhan P, Soroosh D, Peyroshabany B, Javadinia SA. COVID-19 in cancer and non-cancer patients. Int J Cancer Manag. 2021; 14: e110907.

    Article

    Google Scholar

  • Javadinia SA, Ariamanesh M, Nabavifard M, Porouhan P, PeyroShabany B, Fazilat-Panah D, et al. Multicenter study of antibody seroprevalence against COVID-19 in patients presenting with Iranian cancer centers after one year of COVID-19 pandemic. Cancer Invest. 2022; 40 (2): 115–23.

    CAS
    Article

    Google Scholar

  • Su F. COVID-19 and cirrhosis: a combination we must strive to prevent. Gastroenterology. 2021; 161 (5): 1371-3.

    CAS
    Article

    Google Scholar

  • Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, et al. Results after SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021; 74 (3): 567-77.

    CAS
    Article

    Google Scholar

  • Iavarone M, D’Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020; 73 (5): 1063-71.

    CAS
    Article

    Google Scholar

  • Ioannou GN, Liang PS, Locke E, Green P, Berry K, O’Hare AM, et al. Cirrhosis of the liver and severe acute respiratory syndrome coronavirus 2 infection in US veterans: risk of infection, hospitalization, ventilation and mortality. Hepatology. 2021; 74 (1): 322-35.

    CAS
    Article

    Google Scholar

  • Ge J, Pletcher MJ, Lai JC, Harper JR, Chute CG, Haendel MA. Results of SARS-CoV-2 infection in patients with chronic liver and cirrhosis: a national COVID cohort collaboration study. Gastroenterology. 2021; 161 (5): 1487-501.e5.

    CAS
    Article

    Google Scholar

  • Moon AM, Webb GJ, Aloman C, Armstrong MJ, Cargill T, Dhanasekaran R, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020; 73 (3): 705–8.

    CAS
    Article

    Google Scholar

  • Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, et al. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines for the Prevention of Coronavirus Disease 2019 Infection in Patients with Liver Disease. Hepatology. 2021; 74 (2): 1049-64.

    CAS
    Article

    Google Scholar

  • Cornberg M, Buti M, Eberhardt CS, Grossi PA, Shouval D. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver disease, hepatobiliary cancer and liver transplant recipients. J Hepatol. 2021; 74 (4): 944-51.

    CAS
    Article

    Google Scholar

  • Ruether DF, Schaub GM, Duengelhoef PM, Haag F, Brehm TT, Fathi A, et al. SARS-CoV2-specific humoral and T cell immune response after second vaccination in liver cirrhosis and transplant patients. Clin Gastroenterol Hepatol. 2022; 20 (1): 162-72.e9.

    CAS
    Article

    Google Scholar

  • John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D, et al. Association of BNT162b2 mRNA and mRNA-1273 vaccines with COVID-19 infection and hospitalization among patients with cirrhosis. JAMA Trainee Med. 2021; 181 (10): 1306–14.

    CAS
    Article

    Google Scholar

  • John BV, Deng Y, Schwartz KB, Taddei TH, Kaplan DE, Martin P, et al. Post-vaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis. Hepatology. 2022 https://doi.org/10.1002/hep.32337.

    Article
    PubMed

    Google Scholar

  • Mahmud N, Chapin SE, Kaplan DE, Serper M. Identification of patients most at risk of remaining unvaccinated against severe acute respiratory syndrome coronavirus 2 in a large veteran health administration cohort. Lever Transpl. 2021; 27 (11): 1665–8.

    Article

    Google Scholar

  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global study of the potential acceptance of a COVID-19 vaccine. Nat Med. 2021; 27 (2): 225–8.

    CAS
    Article

    Google Scholar

  • Liu R, Zhang Y, Nicholas S, Leng A, Maitland E, Wang J. Covid-19 vaccination willingness among Chinese adults under the free vaccination policy. Vaccines (Basel). 2021; 9 (3): 292.

    CAS
    Article

    Google Scholar

  • Marjot T, Webb GJ, Barritt AS, Ginès P, Lohse AW, Moon AM, et al. SARS-CoV-2 vaccination in patients with liver disease: answer to the next big question. Lancet Gastroenterol Hepatol. 2021; 6 (3): 156–8.

    Article

    Google Scholar

  • Cao Z, Liu Y, Cai M, Xu Y, Xiang X, Zhao G, et al. The use of NACSELD and EASL-CLIF classification systems for ACLF to predict prognosis in inpatients with cirrhosis. Am J Gastroenterol. 2020; 115 (12): 2026–35.

    Article

    Google Scholar

  • Cui X, Wang P, Wei Z. Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) from June 2021. Drug Discov Ther. 2021; 15 (4): 222–4.

    CAS
    Article

    Google Scholar

  • 90% of Chinese were vaccinated against COVID-19. Available at http://en.nhc.gov.cn/2022-01/17/c_85646.html. Accessed February 5, 2022; published online.

  • Shroff H, Satapathy SK, Crawford JM, Todd NJ, VanWagner LB. Liver damage after SARS-CoV-2 vaccination: a multicenter case series. J Hepatol. 2022; 76 (1): 211–4.

    CAS
    Article

    Google Scholar

  • Bril F. Autoimmune hepatitis develops after vaccine against coronavirus disease 2019 (COVID-19): one or even more swallows do not make a summer. J Hepatol. 2021; 75 (5): 1256-7.

    CAS
    Article

    Google Scholar

  • Cao Z, Gui H, Sheng Z, Xin H, Xie Q. Letter to the Editor: Exacerbation of autoimmune hepatitis following COVID-19 vaccination. Hepatology. 2022; 75 (3): 757–9.

    CAS
    Article

    Google Scholar

  • Ai J, Wang J, Liu D, Xiang H, Guo Y, Lv J, et al. Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver disease (CHESS-NMCID 2101): a multicenter study. Clin Gastroenterol Hepatol. 2021 https://doi.org/10.1016/j.cgh.2021.12.022.

    Article
    PubMed
    PubMed Central

    Google Scholar

  • Wang J, Hou Z, Liu J, et al. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): a multicenter study. J Hepatol. 2021; 75 (2): 439-41.

    CAS
    Article

    Google Scholar

  • He T, Zhou Y, Xu P, Ling N, Chen M, Huang T, et al. Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection. Lever Int. 2022 https://doi.org/10.1111/liv.15173.

    Article
    PubMed

    Google Scholar

  • Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with pre-existing liver disease in the United States: a multicenter research network study. Gastroenterology. 2020; 159 (2): 768-71.e3.

    CAS
    Article

    Google Scholar

  • Bajaj JS, Garcia-Tsao G, Biggins SW, Kamath PS, Wong F, McGeorge S, et al. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: ​​multicenter matched cohort. Gut. 2021; 70 (3): 531–6.

    CAS
    Article

    Google Scholar

  • Sarin SK, Choudhury A, Lau GK, Zheng MH, Ji D, Abd-Elsalam S, et al. Existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS study (APASL COVID-19 Liver Injury Spectrum Study). Hepatol Int. 2020; 14 (5): 690-700.

    Article

    Google Scholar

  • Wu J, Li Q, Silver Tarimo C, Wang M, Gu J, Wei W, et al. The hesitation with COVID-19 vaccine among the Chinese people: a large-scale national study. Front Immunol. 2021; 12: 781161.

    Article

    Google Scholar

  • Velardo F, Watson V, Arwidson P, Alla F, Luchini S, Schwarzinger M, et al. Regional differences in hesitation with COVID-19 vaccines in December 2020: a natural experiment in the working-age French population. Vaccines. 2021; 9 (11): 1364.

    CAS
    Article

    Google Scholar

  • Valckx S, Crèvecoeur J, Verelst F, Vranckx M, Hendrickx G, Hens N, et al. Individual factors affecting COVID-19 vaccine acceptance between and during pandemic waves (July-December 2020). Vaccine. 2022; 40 (1): 151-61.

    CAS
    Article

    Google Scholar

  • Joudi M, Moradi Binabaj M, Porouhan P, PeyroShabany B, Tabasi M, Fazilat-Panah D, et al. A cohort study of the immunogenicity and safety of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with breast cancer; does trastuzumab interfere with the outcome? Endocrinol in front. 2022; 13: 798975. https://doi.org/10.3389/fendo.2022.798975.

    Article

    Google Scholar

  • Leave a Reply

    Your email address will not be published.